119 results
8-K
EX-99.1
VANI
Vivani Medical Inc
13 May 24
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
4:57pm
of miniature, long-term GLP-1 implants for the treatment of chronic weight management in obese or overweight patients, type 2 diabetes, and other … miniaturized, long-term drug implants including its lead asset NPM-115 for chronic weight management in obese or overweight patients with one or more risk
8-K
EX-99.2
VANI
Vivani Medical Inc
13 May 24
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
4:57pm
, biopharmaceutical company developing a portfolio of miniature, long-term, drug implants to treat chronic diseases. Our NanoPortal™ platform technology enables … for exenatide and semaglutide NPM-115 target profile may provide an attractive alternative to life-long injections or pills for long-term maintenance
8-K
EX-99.1
m4oz25tjbwhg6v4 4p
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
8-K
EX-99.2
wdlxxnmhb sj8
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
8-K
EX-99.1
q2wok13
6 Mar 24
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
8:30am
8-K
EX-99.1
hghdqq3b4uzq76 vt
5 Mar 24
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
4:21pm
424B5
xm2uo0hi667
5 Mar 24
Prospectus supplement for primary offering
11:31am
8-K
EX-99.1
qrfo qom1hqqjct
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.2
9rau479t872gnzxm
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
lna5fbv604
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.2
86p2q8xu0 jwwwmz5mwl
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.1
vme8 ly3zc8415
18 Sep 23
Regulation FD Disclosure
6:20am
8-K
EX-99.1
cydot066b 55o
28 Aug 23
Entry into a Material Definitive Agreement
5:43pm